Skip to main content

Clinical TrialsSearch 1M+ trials from global registries Drug IntelligenceFollow pipelines from discovery to approval

Global ApprovalsTrack regulatory decisions across 12+ agencies

US FDA Drugs EU EMA Drugs Singapore HSA Drugs China NMPA Drugs Australia TGA Drugs Canada HC Drugs Spain CIMA-AEMPS Drugs UK EMC Drugs Saudi SFDA Drugs Malaysia NPRA Drugs Philippines FDA Drugs Kenya PPB Drugs

AI-Powered ResearchDiscover powerful insights with advanced AI analysis tools for clinical trials.Learn more →Premium AccessGet unlimited access to our comprehensive pharmaceutical database and analytics.Subscribe →

Organizations News Research

Data Sources:ClinicalTrials.govEU CTRFDAEMANMPATGAHealth CanadaWHO ICTRP

Search trials. Track pipelines. Understand approvals. With AI-powered intelligence for clinical research.

Product

Clinical Trials
Drug Intelligence
Global Approvals
AI Research
Pricing

Resources

FAQ
Search

Company

News
About
Contact

Legal

Privacy Policy
Terms of Service

Disclaimer: This website provides information retrieval and data analysis services. The content does not constitute medical advice. Eligibility assessments are for reference only and should not replace consultation with qualified healthcare professionals. Data is sourced from public registries and regulatory agencies; MedPath does not guarantee completeness or accuracy. Always verify information with primary sources.

© 2026 MedPath. All rights reserved.

We value your privacy

We use cookies to analyze site traffic and improve your experience. See our Privacy Policy.

维葡瑞 - NMPA Drug Approval Details

Approvals/NMPA/Velaglucerase Alfa for Injection

Approved

生物制品

Velaglucerase Alfa for Injection

TAKEDA PHARMACEUTICALS INTERNATIONAL AG IRELAND BRANCH🇨🇳 National Medical Products Administration

Approval Date: Feb 9, 2026
Approval ID: 887PQk7eVDC
Company: TAKEDA PHARMACEUTICALS INTERNATIONAL AG IRELAND BRANCH
Type: 生物制品

Approval Details

Approval Id: 887PQk7eVDC
Approval Number: 国药准字SJ20210013
Generic Name: 注射用维拉苷酶α
Generic Name En: Velaglucerase Alfa for Injection
Trade Name: 维葡瑞
Drug Type: 生物制品
Dosage Form: 注射剂
Strength: 目标装量为4.4ml，每瓶的总含量为11mg或440U维拉苷酶α。用4.3ml无菌注射用水复溶后，每瓶将提供4.0ml可抽取体积，其中含有10mg或400U维拉苷酶α。
Reg Date: 2026-02-09
Expired Date: 2031-02-08
Company Name: TAKEDA PHARMACEUTICALS INTERNATIONAL AG IRELAND BRANCH
Company Detail Path: /organization/5117346e6a1b1229/takeda-pharmaceuticals-international-ag-ireland-branch

Approved

Quick Info

Agency

NMPA

Country

🇨🇳

Approval Date

Feb 9, 2026

Approval ID

887PQk7eVDC

Type

生物制品

Back to NMPA Approvals